Trial intelligence / Profile preview

3Mixtatin vs Modified 3Mix in LSTR for Necrotic Primary Molars

NCT05677945Unknown

Sponsor
Cairo University
Start
Mar 2023
Primary completion
Mar 2024
Modality
Small Molecules
01

Overview

Randomised trial of simvastatin gel (Ain Shams University) in pulp necrosis (2 arms), sponsored by Cairo University. Primary endpoints: Absence of pathological mobility at 12 months, Absence of post-operative pain at 12 months and 2 more. Status: unknown.

02

Drugs

simvastatin gel (Ain Shams University)
03

Conditions

pulp necrosis

Beyond the preview

Go deeper on NCT05677945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05677945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call